Natera, Inc.
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30234% above fair value
$378.92−35.38 (-8.54%)
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Licensing and Other Revenues: $4.80M in Q2 2026, up 118.2% from a year earlier.
Latest, Q2 2026
4.80
Period ended Jun 30, 2026
Change on a year earlier
+118.2%
2.20 in Q2 2025
History
37 quarters
Since Q2 2017
Sources
29
Documents cited below
Where the Q2 2026 figure comes from
Source: Form 10-Q (2026-08-07) ↗
Reported in Form 10-K/10-Q (DB).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Licensing and Other Revenues ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 4.80 | +118.2% | Form 10-Q (2026-08-07) ↗ |
| Q1 2026 | Mar 31, 2026 | 2.80 | +55.6% | Form 10-Q (2026-05-08) ↗ |
| Q4 2025 | Dec 31, 2025 | 4.30 | +38.7% | Form 10-K (2026-02-27) ↗ |
| Q3 2025 | Sep 30, 2025 | 2 | -44.4% | Form 10-Q (2025-11-07) ↗ |
| Q2 2025 | Jun 30, 2025 | 2.20 | +10.0% | Form 10-Q (2025-08-08) ↗ |
| Q1 2025 | Mar 31, 2025 | 1.80 | -41.9% | Form 10-Q (2025-05-09) ↗ |
| Q4 2024 | Dec 31, 2024 | 3.10 | -20.5% | Form 10-K (2025-02-28) ↗ |
| Q3 2024 | Sep 30, 2024 | 3.60 | +16.1% | Form 10-Q (2024-11-12) ↗ |
| Q2 2024 | Jun 30, 2024 | 2 | -35.5% | Form 10-Q (2024-08-09) ↗ |
| Q1 2024 | Mar 31, 2024 | 3.10 | -22.5% | Form 10-Q (2024-05-10) ↗ |
| Q4 2023 | Dec 31, 2023 | 3.90 | -11.4% | Form 10-K (2024-02-29) ↗ |
| Q3 2023 | Sep 30, 2023 | 3.10 | -71.3% | Form 10-Q (2023-11-09) ↗ |
| Q2 2023 | Jun 30, 2023 | 3.10 | -13.9% | Form 10-Q (2023-08-04) ↗ |
| Q1 2023 | Mar 31, 2023 | 4 | -2.4% | Form 10-Q (2023-05-10) ↗ |
| Q4 2022 | Dec 31, 2022 | 4.40 | -36.2% | Form 10-K (2023-03-01) ↗ |
| Q3 2022 | Sep 30, 2022 | 10.8 | +157.1% | Form 10-Q (2022-11-09) ↗ |
| Q2 2022 | Jun 30, 2022 | 3.60 | +50.0% | Form 10-Q (2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 4.10 | -87.1% | Form 10-Q (2022-05-06) ↗ |
| Q4 2021 | Dec 31, 2021 | 6.90 | +16.9% | Form 10-K (2023-03-01) ↗ |
| Q3 2021 | Sep 30, 2021 | 4.20 | -14.3% | Form 10-Q (2022-11-09) ↗ |
| Q2 2021 | Jun 30, 2021 | 2.40 | -60.7% | Form 10-Q (2022-08-05) ↗ |
| Q1 2021 | Mar 31, 2021 | 31.9 | +355.7% | Form 10-Q (2022-05-06) ↗ |
| Q4 2020 | Dec 31, 2020 | 5.90 | -33.0% | Form 10-K (2021-02-26) ↗ |
| Q3 2020 | Sep 30, 2020 | 4.90 | -55.5% | Form 10-Q (2020-11-06) ↗ |
| Q2 2020 | Jun 30, 2020 | 6.10 | -34.4% | Form 10-Q (2020-08-07) ↗ |
| Q1 2020 | Mar 31, 2020 | 7 | +100.0% | Form 10-Q (2020-05-08) ↗ |
| Q4 2019 | Dec 31, 2019 | 8.80 | +125.6% | Form 10-K (2020-03-02) ↗ |
| Q3 2019 | Sep 30, 2019 | 11 | +323.1% | Form 10-Q (2019-11-08) ↗ |
| Q2 2019 | Jun 30, 2019 | 9.30 | +244.4% | Form 10-Q (2019-08-09) ↗ |
| Q1 2019 | Mar 31, 2019 | 3.50 | -56.8% | Form 10-Q (2019-05-10) ↗ |
| Q4 2018 | Dec 31, 2018 | 3.90 | +85.7% | Form 10-K (2019-03-15) ↗ |
| Q3 2018 | Sep 30, 2018 | 2.60 | +85.7% | Form 10-Q (2018-11-09) ↗ |
| Q2 2018 | Jun 30, 2018 | 2.70 | +92.9% | Form 10-Q (2018-08-09) ↗ |
| Q1 2018 | Mar 31, 2018 | 8.10 | – | Form 10-Q (2019-05-10) ↗ |
| Q4 2017 | Dec 31, 2017 | 2.10 | – | Form 10-K (2019-03-15) ↗ |
| Q3 2017 | Sep 30, 2017 | 1.40 | – | Form 10-Q (2018-11-09) ↗ |
| Q2 2017 | Jun 30, 2017 | 1.40 | – | Form 10-Q (2018-08-09) ↗ |
Cite this data
StockData. (2026). Natera Licensing and Other Revenues ($M), quarterly Q2 2017–Q2 2026 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/db-seg-licensing-rev
See every metric in the Natera KPI table. Data updated Nov 2, 2026.